Literature DB >> 23038690

Fluorescence in situ hybridisation analysis of bone marrow trephine biopsy specimens; an additional tool in the diagnostic armoury.

Michael J Neat1, Mufaddal T Moonim, Robert G Dunn, Helen Geoghegan, Nicola J Foot.   

Abstract

Fluorescence in situ hybridisation (FISH) analysis is now widely employed in the diagnosis and risk stratification of a wide range of malignant diseases. While this technique is used successfully with formalin-fixed paraffin-embedded (FFPE) sections from numerous tissue types, FISH analysis of FFPE tissue sections from trephine biopsy specimens has been less widely reported, possibly due to technical limitations relating to the decalcification protocols employed. During the last 4 years FISH analysis has been carried out successfully in 42 out of 55 (76%) consecutive trephine biopsy specimens received as part of the standard diagnostic service at our institution. Samples decalcified using EDTA-based protocols were analysed successfully in 31/31 cases (100%), whereas only 11/24 samples (46%) decalcified using formic acid-based protocols were successful. In our experience, FISH analysis of trephine biopsy specimens is a highly reproducible technique and a very useful adjunctive tool in the diagnostic armoury; however, its use in a standard diagnostic setting relies on the use of EDTA-based decalcification protocols.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038690     DOI: 10.1136/jclinpath-2012-201131

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome.

Authors:  Marian Jpl Stevens-Kroef; Konnie M Hebeda; Eugène T Verwiel; Eveline J Kamping; Patricia H van Cleef; Roland P Kuiper; Patricia Jta Groenen
Journal:  Mol Cytogenet       Date:  2015-05-28       Impact factor: 2.009

2.  Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

Authors:  Takayuki Murase; Masaki Ri; Tomoko Narita; Keiichiro Fujii; Ayako Masaki; Shinsuke Iida; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2019-07-11       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.